The authors examined associations between cumulative smoking during a woman's first and second pregnancies and risk of placental abruption in the second pregnancy. They performed a population-based prospective cohort study of 526,690 women who delivered their first two consecutive singletons in Sweden in 1983-2001. Using logistic regression models, the authors found that, among women without placental abruption in the first pregnancy, smoking was associated with increased risk of abruption in the second pregnancy; however, this effect was confined to exposure occurring during the second pregnancy (adjusted odds ratio (OR) ¼ 1.8, 95% confidence interval (CI): 1.4, 2.3) but not the first (adjusted OR ¼ 1.1, 95% CI: 0.9, 1.3). Among women with a prior abruption, the risk of repeating abruption was increased irrespective of smoking habits. When women smoked during both pregnancies, there was an almost 11-fold increase in risk (adjusted OR ¼ 10.9, 95% CI: 7.3, 16.3). These findings suggest that women who quit smoking before pregnancy may benefit from reduced risk of abruption. The observation that the recurrence of abruption is substantially increased regardless of changes in smoking habits suggests that factors other than smoking may influence the recurrence of placental abruption. abruptio placentae; pregnancy; recurrence; risk; smoking Abbreviations: ICD, International Classification of Diseases; SGA, small-for-gestational-age.
Approximately 10-20 percent of women in industrialized countries smoke during their pregnancies. During the past several decades, smoking during pregnancy has remained one of the most consistently reported-and modifiablerisk factors for an array of maternal and perinatal outcomes, including restricted fetal growth, preterm delivery, and placental abruption (1, 2) .
Placental abruption is a devastating obstetric complication that is associated with excessively high rates of stillbirth, preterm birth, and reduced fetal growth (3) (4) (5) (6) (7) (8) (9) . While the etiology of abruption remains largely speculative, risk factors associated with it include advanced maternal age, multiparity, cocaine use during pregnancy, preeclampsia, intrauterine infection, oligohydramnios, prolonged rupture of membranes, and prior abruption (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) . Smoking during pregnancy has also been shown to be associated with abruption; relative risks range from 1.5 to 2.5, with a strong dosedependent relation with amount smoked per day (1, 8, 17, 19, 20) .
It remains unknown whether the toxic effect of maternal smoking on abruption risk is restricted to the pregnancy during which the mother smokes (i.e., a direct effect) or whether cumulative exposure to smoking across pregnancies confers increased risk (i.e., a cumulative effect). We tested these hypotheses in a large cohort of over half a million women with two consecutive singleton births. 
MATERIALS AND METHODS

Study design and cohort composition
The Swedish Medical Birth Register includes information prospectively collected during pregnancy, delivery, and the neonatal period on virtually all births in Sweden. From 1983 through 2001, 1.9 million singleton births were recorded in the Swedish Birth Register. Each woman is assigned a unique national registration number, enabling linkage of successive births to each woman within the register. Data on sociodemographic characteristics, reproductive history, and complications during pregnancy, delivery, and the neonatal period are prospectively collected beginning with the first antenatal visit. These data are forwarded to the Birth Register through copies of standardized individual antenatal, obstetric, and pediatric records. The current study was restricted to women who had delivered their first two consecutive singletons (526,690 women).
Data on smoking were ascertained by a midwife at the woman's first prenatal care visit, which occurs before the 15th week of gestation in over 95 percent of the pregnancies in Sweden (21) . Mothers were categorized with regard to self-reported smoking as nonsmokers (including nondaily smoking), moderate smokers (1-9 cigarettes/day), or heavy smokers (10 cigarettes/day). Maternal age at first delivery was categorized as <25, 25-29, 30-34, or 35 years. Through linkage with the Education Register, number of years of formal education completed as of December 2001 was obtained from Statistics Sweden, and education was categorized as 11 years and 12 years. Interpregnancy interval was calculated as the number of months between the birth of the first child and the estimated date of conception of the following child, and was categorized as <5, 6-11, 12-23, 24-35, 36-47, or 48 completed months.
Gestational age was largely based on early second-trimester ultrasound examination, when available, or was estimated from the date of the last menstrual period. Early ultrasound examination gradually became increasingly common in Sweden during the 1980s and has been offered to all pregnant women since 1990. Approximately 95 percent of the women accept this procedure (22) .
Complications arising during pregnancy and delivery were classified according to the International Classification of Diseases (ICD), Eighth (1983 Eighth ( -1986 , Ninth (1987 Ninth ( -1996 , or Tenth (since 1997) revision. Placental abruption was defined using ICD-8 codes 632.1 and 651.4, ICD-9 code 641C, and ICD-10 code O45; preeclampsia was defined using ICD-9 codes 642E-H and ICD-10 codes O11 and O14; and pregestational diabetes was defined using ICD-9 code 648A and ICD-10 codes O24.0-O24.3. Since the ICD-8 did not permit separation of nonproteinuric gestational hypertension from proteinuric gestational hypertension or separation of pregestational diabetes from gestational diabetes, we were unable to define preeclampsia or pregestational diabetes for births occurring between 1983 and 1986. The study was approved by the ethics research committee at the Karolinska Institutet, Stockholm, Sweden.
Statistical analysis
Associations between maternal smoking and risk of abruption in the second pregnancy were evaluated using smoking as both an indicator (smoker or nonsmoker) and an ordinal factor categorized as nonsmoker, moderate smoker, and heavy smoker. We evaluated whether the association between smoking and abruption risk in the second pregnancy was one of a ''direct'' effect (i.e., confined to smoking exposure in the second pregnancy) or whether cumulative exposure (i.e., smoking in both the first and the second pregnancies) was associated with increased risk. This was accomplished by comparing risks with women categorized as a nonsmoker in both pregnancies (reference group), a smoker in the first pregnancy but not in the second pregnancy, a nonsmoker in the first pregnancy but a smoker in the second pregnancy, or a smoker in both pregnancies.
We used logistic regression analyses to evaluate associations between smoking habits and abruption risk. Odds ratios and 95 percent confidence intervals were derived from these models and were used to approximate relative risks. These logistic regression models were adjusted for two sets of factors: 1) covariates that included maternal age, education, interpregnancy interval, country of birth, and year of second delivery and 2) all of the confounders listed above, plus preeclampsia and pregestational diabetes in the second pregnancy and perinatal outcomes in the first pregnancy. Country of birth, obtained through linkage to the Migration Register, was stratified into Sweden, other Nordic countries (Denmark, Norway, Finland, and Iceland), and non-Nordic countries. To account for temporal changes in smoking prevalence and abruption, we adjusted all analyses by year of the second birth (grouped as 1983-1989, 1990-1993, 1994-1997, and 1998-2001) .
Fetal and infant outcomes in the first pregnancy were hierarchically grouped as follows: 1) stillbirths occurring at 28 weeks; 2) very preterm (gestational age <32 weeks) small-for-gestational-age (SGA) births; 3) moderately preterm (gestational age 32-36 weeks) SGA births; 4) full-term (gestational age 37 weeks) SGA births; 5) very preterm non-SGA births; 6) moderately preterm non-SGA births; and 7) full-term non-SGA births. SGA birth was defined as a birth weight less than two standard deviations below the mean for gestational age, based on the Swedish reference curve (23) .
RESULTS
Rates of placental abruption in the first and second pregnancies were 0.49 percent and 0.41 percent, respectively. Women with an abruption in their first pregnancy were at a greater than 11-fold increased risk (odds ratio ¼ 11.6, 95 percent confidence interval: 9.5, 14.1) of developing a recurrent abruption (table 1) .
The association between changes in smoking habits in the first and second pregnancies and risk of placental abruption in the second pregnancy is shown in table 2. The effect of smoking on risk of abruption in the second pregnancy was largely confined to smoking in the second pregnancy. In * Adjusted for maternal age at second birth, maternal education, country of birth, interpregnancy interval, and birth year. y Adjusted for the covariates included in the first adjusted model, as well as for placental abruption and birth outcomes in the first pregnancy, and preeclampsia and pregestational diabetes in the second pregnancy.
z OR, odds ratio; CI, confidence interval.
comparison with women who were nonsmokers in both pregnancies, the risk of abruption in the second pregnancy increased with the amount smoked during the second pregnancy. Women who quit smoking before the second pregnancy had risks for abruption similar to those of women who were nonsmokers in both pregnancies. We examined whether the association between maternal smoking habits in successive pregnancies and placental abruption in the second pregnancy persisted among women who did and did not experience abruption in their first pregnancy (table 3) . Among women with no abruption in their first pregnancy, the risk of abruption in the second pregnancy increased when women initiated smoking in their second pregnancy or smoked during both pregnancies (as compared with nonsmoking in both pregnancies), while women who stopped smoking during their second pregnancy were not at increased risk of placental abruption. In contrast, among women who experienced abruption in the first pregnancy, the risk of recurrent abruption was high regardless of smoking habits in either the first or the second pregnancy. However, if women smoked during both their first and second pregnancies, the risk of abruption in the second pregnancy was almost 11-fold higher (odds ratio ¼ 10.9, percent confidence interval: 7.3, 16.3) in comparison with women who remained nonsmokers in both of their pregnancies. Although these associations were significant, they deserve cautious interpretation owing to the fairly wide confidence intervals.
DISCUSSION
We found that the risk of abruption in the second pregnancy is reduced when women quit smoking between their first and second pregnancies and is increased when women start smoking. These findings indicate that the adverse effect of maternal smoking on abruption risk is largely confined to a direct toxic effect of smoking exposure during pregnancy. Among women with a history of abruption, the risk of recurrent abruption is increased dramatically, even among nonsmokers and women who quit smoking, suggesting that other, unobserved determinants shape the risk of recurrent placental abruption.
In previous studies, investigators have consistently reported dose-response relations between maternal smoking and risk of abruption (1, 6, 8, 12) . We found that a change in exposure to tobacco smoke between pregnancies influences the risk of abruption. The reduced risk of abruption in the second pregnancy when women stopped smoking between their first and second pregnancies suggests that the effect of maternal smoking on abruption risk is one that is probably transient.
Biologic interpretations
Microscopic studies of the placenta have suggested that tobacco use leads to vasoconstriction of the arterioles and placental underperfusion surrounding the site of implantation (24, 25) . These two processes result in rigidity in arteries and consequently lead to decidual and maternal floor infarctions and hemorrhage, and eventually to abruption (26) .
Biases and limitations
The findings of our study warrant some caution in interpretation, owing to a few limitations. Foremost among them is the fact that details regarding smoking habits, although ascertained prior to any untoward pregnancy outcome, were based entirely on maternal self-reporting early in pregnancy. Widely publicized information on the harmful effects of smoking may have caused some women to underreport their smoking (27) . Furthermore, some smokers may have falsely reported that they were nonsmokers, and others may have quit smoking after their first prenatal care visit, after information about smoking was recorded (28) . If anything, these limitations would have led to an underestimation of smoking-related risk of placental abruption. On the other hand, if a woman reported that she was a smoker early in pregnancy and then quit smoking shortly thereafter, this may have led to overestimation of the effects of smoking on abruption risk. Residual confounding due to unmeasured factors (e.g., passive exposure to tobacco smoke and use of drugs) may also have influenced our findings. The validity of the diagnosis of placental abruption may be a concern. In Sweden, the definition of abruption is entrusted to clinicians. We are unaware of whether the low prevalence of reported abruption in the first and second pregnancies reflects the possibility that abruption is relatively less common in Sweden than in other countries (11, 29) or reflects a low sensitivity of the diagnosis. However, a quality study of the Swedish Medical Birth Registry showed minimal variability across hospitals with respect to the prevalence of abruption (30) . More importantly, a previous validation study carried out in Sweden reported good correspondence between the diagnosis of abruption as reported by ICD codes and the clinical picture of abruption as documented in individual delivery records (31) . The diagnosis of abruption in this study was based on ICD codes, and different versions of the ICD (ICD-8 through ICD-10) have been used over the years. However, we did not find that the prevalence of abruption was markedly influenced by year of birth, which also was included as a covariate in the analyses.
Strengths
The population-based nature of this study permits generalizability of findings across Sweden and perhaps to other countries as well. Since all Swedish residents have a unique national registration number, successive linkage of individual information from first pregnancies to second pregnancies was virtually complete. The population of pregnant women in Sweden is fairly homogeneous, with widespread availability of and access to prenatal care, which is regularly used by the vast majority of women (30) . Ascertainment of smoking data and other data collection efforts were accomplished prospectively, precluding recall and selection biases.
The observation of an increased risk of recurrent abruption among women who stopped smoking during the second pregnancy, in comparison with women who were nonsmokers in both pregnancies, is intriguing. This suggests that other, unobserved factors-factors stronger than maternal smoking-may influence the risk of recurrent abruption. In searching for other causes of placental abruption, a strong genetic predisposition is one that may explain the 11-fold increased risk of recurrence of placental abruption (32) (33) (34) . Although large-scale studies evaluating a genetic predisposition to abruption are largely lacking, a study of maternal and fetal genes and imprinting of paternal alleles, as well as genetic effects modified through environmental exposures, may yield informative data on the problem of recurrent abruption.
Conclusions
These findings strongly suggest that there is a causal association between maternal smoking during pregnancy and risk of placental abruption. These data lend credence to the interpretation that the adverse impact of maternal smoking on increased risk of abruption is largely confined to the pregnancy in which the exposure occurs. Among women with no placental abruption in the first pregnancy, the observation that the risk of abruption in the second pregnancy diminishes when women quit smoking between pregnancies is encouraging. While primary prevention of smoking is best, intensive efforts to promulgate information regarding the harmful consequences of smoking in human reproduction should be encouraged.
